Compare OLPX & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OLPX | SLP |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | EDP Services |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 680.9M | 322.4M |
| IPO Year | 2021 | 1997 |
| Metric | OLPX | SLP |
|---|---|---|
| Price | $1.26 | $19.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $1.81 | ★ $26.80 |
| AVG Volume (30 Days) | ★ 1.1M | 409.9K |
| Earning Date | 11-06-2025 | 01-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $418,582,000.00 | $79,179,000.00 |
| Revenue This Year | $2.15 | $2.02 |
| Revenue Next Year | $2.31 | $6.92 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.09 |
| 52 Week Low | $0.99 | $12.39 |
| 52 Week High | $2.13 | $37.67 |
| Indicator | OLPX | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 58.72 | 58.86 |
| Support Level | $1.20 | $19.20 |
| Resistance Level | $1.20 | $20.06 |
| Average True Range (ATR) | 0.07 | 0.88 |
| MACD | 0.02 | 0.08 |
| Stochastic Oscillator | 62.25 | 61.66 |
Olaplex Holdings Inc is a science-enabled, technology-driven beauty company. It offers science-backed solutions that improve hair health. It identifies the majority of consumers' relevant haircare concerns in collaboration with the community of professional hairstylists and consumers and strives to address them through its proprietary technology and innovation capabilities. It offers products through an omnichannel platform that serves professional, specialty retail, and DTC channels. The company derives its revenue through the sale of its hair care products. The company generates the majority of revenue from Professional sales channels followed by Specialty Retail and then DTC. Geographically the company generates the majority of its revenue from the International market.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.